Flyer

Archives of Clinical Microbiology

  • ISSN: 1989-8436
  • Journal h-index: 24
  • Journal CiteScore: 8.01
  • Journal Impact Factor: 7.55
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • Open Archive Initiative
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • Scimago Journal Ranking
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Research Article - (2020) Volume 11, Issue 1

Prevalence of Community Acquired Methicillin Resistant Staphylococcus aureus Nasal Carriage among Children of Consultation: Experience of a Moroccan University Hospital

Ed-dyb S1,3*, Aboudourib M2,3, Azzouzi F2,3, Quiddi W1,3, Akhdari N2,3, Amal S2,3, Soraa N1,3and Hocar O2,3

1Bacteriology-Virology Department, Mohammed VI CHU, 53 Ibn Sina Boulevard, Assif D, 40080 Marrakech, Morocco

2Dermatology Department, Mohammed VI CHU, 53 Ibn Sina Boulevard, Assif D, 40080 Marrakech, Morocco

3Faculty of Medicine and Pharmacy-Cadi Ayyad University, Sidi Abbad, B.P. 7010, 40000 Marrakech, Morocco

*Corresponding Author:
Saida Ed-dyb
Bacteriology-Virology Department, Mohammed VI CHU
53 Ibn Sina Boulevard, Assif D, 40080
Marrakech, Morocco
Tel: 00212667504774
E-mail: saeddyb@gmail.com

Received Date: November 01, 2019; Accepted Date: December 24, 2019; Published Date: January 04, 2020

Citation: Ed-dyb S, Aboudourib M, Azzouzi F, Quiddi W, Akhdari N, et al. (2020) Prevalence of Community Acquired Methicillin Resistant Staphylococcus aureus nasal carriage among children of consultation: Experience of a Moroccan University Hospital. Arch Clin Microbiol Vol. 11 No. 1:100

Copyright: © 2020 Ed-dyb S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Archives of Clinical Microbiology

Abstract

Background: The carriage of Staphylocoque aureus, including methicillin-resistant S. aureus (MRSA), is a significant risk factor for subsequent staphylococcal infection. The nares are the most consistent sites of colonization. The objective of this study was to determine prevalence for community acquired methicillin-resistant S. aureus (CA-MRSA) nasal carriage among a pediatric population as well as to find out antibiotic susceptibilities of isolated strains.
Patients and methods: We conducted a prospective study from June 2017 to June 2018 on 300 children, who consulted in the different pediatric specialties of Mohamed VI University Hospital of Marrakesh. Nasal swabs were collected from all the consultant children. The identification of nasal carriage of SA was performed in the microbiology laboratory of Mohamed VI University Hospital.
Results: Staphylocoque aureus was isolated from the nares in 49 (16.3%) children, two (4%) isolates were classified as CA-MRSA. The mean children age was 75, 14 months (p=0.05), a male predominance was noticed. The majority of SA carriers were from urban areas, it was noted a high carriage in living patients with five or more people (p=0.024). Antimicrobial susceptibility testing of MRSA stains expressed a 100% resistance to cotrimoxazole, fusidic acid and sensitivity to all other antibiotics.
Conclusion: This study highlights the potential for community MRSA acquisition in our context. These
strains, which were initially sensitive to most of antibiotics, begin to become increasingly resistant to nobetalactam antibiotics. This requires continuous monitoring to clarify the factors of antimicrobial resistance and to prevent further spread of community MRSA.
 

Keywords

Methicillin-resistant Staphylococcus aureus; Nasal carriage; Communal; Children

Introduction

Staphylococcus aureus is a commensal bacterium of the cutaneous and mucous flora of man. Permanent nasal carriage is found in 30% of individuals [1,2]. It is one of the most common causes of pediatric infections worldwide, manifesting itself in a range of diseases, ranging from a minor skin infection to a serious and deadly invasive disease [3].

These infections are a real public health problem both by the virulence of the bacteria and the emergence of multiresistant strains to antibiotics. The first reported cases of methicillin-resistant S. aureus infection (MRSA) are more than 30 years old and have a nosocomial character, with the acquisition of MRSA related to recent hospitalization or prolonged and recurrent exposure to antibiotics.

Recent studies have documented that the epidemiology of MRSA has changed, as the isolation of MRSA is no longer contained to hospital settings or patients with predisposing risk factors [4,5], Asymptomatic CA-MRSA colonization has been noticed in healthy children attending the emergency departments and outpatient clinics of children ’ s hospitals. These are community-acquired MRSA infections (CA-MRSA) [6].

Nasal or skin colonization of S. aureus, including MRSA, is quite common among children, and constitutes a major risk factor for subsequent invasive staphylococcal infection. The ecological niches of S. aureus strains are the anterior nares [7].

Given the relationship between nasal carriage and risk of infection, knowledge of the prevalence of nasal MRSA carriage in a community provides sense of probability of acquiring an MRSA infection in that community [8].

In the current study, which was the first in Morocco, we aimed to address the extent of this issue by evaluating the nasal carriage prevalence and antimicrobial resistance profiles of S. aureus and CA-MRSA in healthy children.

Materials and Methods

Setting and population

This prospective observational study was conducted from June 2017 to June 2017 at the pediatric consultation of Mohamed VI University Hospital.

A total of 300 patients having 15 years or under were in subject to the study, excluding those having taken an antibiotic during the previous 3 months, those with hospitalization record in the previous 6 months, with a chronic disease (diabetes, hemodialysis, asthma, … ), and those having immunodeficiency (primitive, acquired, or iatrogenic) or indwelling catheters.

Statistical analysis

A convenient sample technique was used for sample selection. Results were compiled, tabulated and all data were subjected to SPSS, version17.0 software statistical package for analysis. Association was done using Chi-square test. A p-value of <0.05 was considered significant.

Questionnaire and ethical considerations

Written questionnaires concerning demographics and medical history were completed by the children’s parents. An informed consent is approved by parents.

Procedure of sampling

Procedure of nasal sampling

• Take sterile dry cotton swab (soaked in 0.5 ml of sterile physiological saline).

• Insert the swab into the patient's anterior nostril (1-2 cm) and collect nasal secretions by performing 2 to 3 full rotations of the swab.

• Repeat the same procedure in the other nostril of the patient without changing the swab.

Procedure of skin sampling

A skin sample was taken from children with dermatological lesions

• The gallbladder, bubble or pustule was opened using a sterile needle

• A swab was made

• Then the swab was placed in its carrying case.

The samples were sent to the microbiology laboratory in less than 4 hours.

Microbiological methods

The bacteriological study and the study of antibiotic susceptibility were carried out in the microbiology department of Med VI University Hospital.

The inoculation of the collected swabs was done on Mannitol salt agar medium. The plates were incubated aerobically at 37°C for 24 hours and they were examined for growth. The Staphylococcus aureus which was isolated from samples was identified by standard methods based on morphological criteria (Gram-positive Cocci in clusters), culture (pigmented colonies), biochemical (mannitol fermentation, catalase, production, coagulase, biochemical tests). The identification and antibiogram were performed in liquid medium by the BD Phoenix® system. The confirmation of Meticillin resistance was made by a cefoxitin disk on agar medium (Müller Hinton medium). MRSA was confirmed by the disc diffusion method by using cefoxitin (30 mcg) and also by its growth on Oxacillin Resistant Screen Agar. The results were interpreted according to the recommendations of the Committee on antibiogram of the French Microbiology Society CA-SFM EUCAST [9]. The following antibiotics were tested: penicillin G, cefoxitin, erythromycin, lincomycin, pristinamycin, cotrimoxazole, fusidic acid, fosfomycin, rifampicin, kanamycin, gentamicin, tobramycin, ciprofloxacin, vancomycin, teicoplanin, tetracycline, linezolid and mupirocin.

Results

A total of 300 children consulting at different pediatric specialties were enrolled in this study (Table 1).

Table 1 Frequency distribution of S. aureus nasal carriage based on different pediatric specialties.

Specialty No. of subjects (%) No.of subjects (%) with S. aureus
Pediatric emergencies 115 (38.3%) 15 (13%)
pediatric dermatology 105 (35%) 19 (18%)
Pediatrics 57 (19%) 9 (16%)
Infant surgery 19 (6.3%) 4 (21%)
Neonatology 4 (1.3%) 2 (50%)

Their age is ranging from 1 to 180 months, with a mean age of 60.45months.

55.7% (n=167) were boys. The majority of consultants (93%) did not have a particular pathological history. Infectious pathology was the most frequent reason for consultation with 60% of cases. Fever, respiratory discomfort and cough dominated the clinical symptomatology, with the percentages being (60%), (20%) and (14%) respectively. Six patients were carriers of cutaneous lesions.

Forty nine strains of Staphylococcus aureus were isolated, giving a prevalence of nasal carriage of S. aureus of 16.33% (49/300), (95% confidence interval [CI]:12.1-20.5).

The prevalence of MRSA was 0.66% (2/300), this figure corresponds to 4% (2/49) of S. aureus isolates. Skin and nasal samples were positive in children with dermatological lesions.

The mean age in children with S. aureus nasal carriage was 75.14 months (p=0.05). A male predominance was noted (sex ratio M/F=1.33).

The prevalence of SA nasal carriage was higher in the summer (p=0.068) and most patients identified having SA nasal carriage were from urban areas (76%) and 24% from rural areas (p=0.214). The community life represented essentially by the number of close contacts under the same roof with the patient, it was noted a high carriage in living patients with five or more people (0.024).

Among the 300 children included in the study the statistically significant risk factor for nasal colonization of S. aureus was number of members of joint families (Table 2).

Table 2 Frequency repartition of S. aureus and CA-MRSA nasal carriage based on demographic variables.

Variable n (%) S. aureus nasal carriage n (%) p-value CA-MRSA nasal carriage n (%)
Positive Negative Positive Negative
Age group (years)
0-3 84 (28) 19 (6.33) 65 (21.66) 0.05 1 (0.33) 83 (27.66)
>3-6 60 (20) 5 (1.66) 55 (18.33) 1 (0.33) 59 (19.66)
>6-10 84 (28) 13 (4.33) 71 (23.66) 0 84 (28)
>10-15 72 (24) 12 (4) 60 (20) 0 72 (24)
Sex
Male 167 (55.66) 28 (9.33) 139 (46.33) 0.352 2 (0.66) 165 (55)
Female 133 (44.33) 21 (7) 112 (37.33) 0 133 (44.33)
Season
Summer 164 (54.66) 32 (10.66) 132 (44) 0.068 1 (0.33) 163 (54.33)
Winter 136 (45.33) 17 (5.66) 119 (39.66) 1 (0.33) 135 (45)
Dwelling
Urban 237 (79) 37 (12.33) 200 (66.66) 0.214 0 237 (79)
Rural 63 (21) 12 (4) 51 (17) 2 (0.66) 61 (20.33)
Number of members of joint families
<5 160 (53.33) 11 (3.66) 149 (49.66) 0.024 1 (0.33) 159 (53)
≥5 140 (46.66) 38 (12.66) 102 (34) 1 (0.33) 139 (46.33)

CA-MRSA: Community-acquired methicillin-resistant.

The two children with CA-MRSA, were male, and they were 42 months and 26 months respectively.

They had no contact with a person with a current skin lesion. Both patients came from rural areas. The close contacts living with them under the same roof were 5 people for the first case and 4 people for the second.

One of our patients was seen in pediatric emergencies for progressive symptoms and signs of motor weakness develop rapidly of two limbs. The Guillain Barré Syndrome was retained after a complete assessment.

The 2nd patient was seen at the pediatric dermatology consultation where he was being followed for atopic dermatitis.

The study of the antibiotic susceptibility of the 49 strains of S. aureus showed that apart penicillin G, S. aureus strains were sensitive to other antibiotics. No acquired resistance was found in methicillin-sensitive S. aureus strains.

Isolated MRSA strains remained sensitive for other families of antibiotics including erythromycin, linezolid, pristinamycin, rifampicin, fluoro-quinolones and glycopeptides. These strains expressed a 100% resistance to cotrimoxazole and fusidic acid and a 50% to kanamycin (Table 3).

Table 3 Sensitivity of CA-MRSA Strains to Antibiotics.

Antibiotic Susceptibility (%)
Penicillin G 0
Cefoxitin 0
Gentamycin 100
Kanmycin 50
Tobramycin 100
Daptomycin 100
Teicoplanin 100
Vancomycin 100
Erythromycin 100
Pristinamycin 100
Linezolid 100
Levofloxacin 100
Rifampicin 100
Tetracyclin 100
Tigecyclin 100
Cotrimoxazole 0
Fucidic acid 0

The bacteriological data had demonstrated that the resistance of the two MRSA-C strains is mediated by the mec A gene.

Discussion

S. aureus is a bacterium that has the ability to asymptomatically colonize human mucosa for varying periods of time [10,11]. Its carriage is frequent in the pediatric population [12]. Nasal carriage of MRSA has been verified as a significant risk factor for MRSA infection. The first cases of MRSA infection were reported more than 30 years ago and had a nosocomial character, the acquisition of MRSA being related to recent hospitalization or prolonged and recurrent exposure to antibiotics.

After nearly three decades of being solely confined to hospitals and long-term care facilities, MRSA has emerged in various geographically distinct communities outside of health care settings, without known health care-associated risk factors [13].

In 2000, the CDC created a case definition for a CA-MRSA infection: any MRSA infection diagnosed for an outpatient or within 48 h of hospitalization if the patient lacks the following health care-associated MRSA risk factors: hemodialysis, surgery, residence in a long-term care facility or hospitalization during the previous year, the presence of an indwelling catheter or a percutaneous device at the time of culture, or previous isolation of MRSA from the patient [14,15].

This study from Morocco reports the nasal carriage of S. aureus and MRSA_C among healthy children in the community in the age group of 1 month to 15 years.

Our study showed that 16.33% of healthy children attending pediatric consultation of Mohamed VI University Hospital Center, were colonized with S. aureus in the anterior nares. Our findings are consistent with previous reports: In a study from Andhra Pradesh, India, a carriage rate of 16% for S. aureus was documented [16]. Studies from Taiwan, US, Iran have documented prevalence of nasal carriage of S. aureus among children ranging from 16%, 23% and 28% respectively. [13,17,18].

In contrast, Chaterjee et al. [19] studied 489 school children aged 5-15 years by PCR and found nasal colonization of S. aureus in 256 (52.5%) of children, which is much higher compared to our study and other reports [19]. Other studies from tunis and Tanzania have documented a carriage rate of 47%, 40 % respectively [20,21].

The comparatively higher prevalence rate may be attributed to the characteristics of the study population, although other factors may have played a contributory role.

Studies have shown that colonization with S. aureus varies with age [22-24] with a peak at 2-3 years [22]. Similarly, in our study the predominant age groups were 0 to 3 years and 6 to 10 years. These differences were not statistically significant.

In our study, the statistically significant risk factor for nasal colonization of S. aureus was living with more than 5 persons. The study conducted by Shetty et al. (India) [5] has shown that the prevalence of SA carriers is higher in patients living with 10 people compared to patients with close contacts ≤4; this could be due to poor hygiene and overcrowding. Another study done by Chen et al. (Taiwan) reported that living with more children is an important factor for colonization with MRSA [25].

The low prevalence of MRSA (0.66%) in the current study concurs with findings of resource-limited countries: in the studies done in Ghana by Eibach et al. [37], in Malaysia by Azmawati et al. [26], in Ahvaz, Iran by Nikfar et al. [27], and in Szolnok, Hungary by Krisztina et al. [28], the rates are respectively 2%, 1.6%, 1.3% and 0.8% but these findings are in contrast with previous reports from other countries, which documented height prevalence of MRSA colonization among healthy children in the community ranging from 13.2% to 22% [29-31].

In one study from the US, the nasal colonization rate of MRSA among healthy children increased from 0.8% in 2001 to 9.2% in 2004 [25,32].

The high MRSA carriage in healthy children is of great importance because MRSA colonization may subsequently cause infections [5], has been reported to be associated with outbreaks in a pediatric hospital resulting in the death of children [33], also asymptomatic colonization can persist for months to years [34] and the potential for spread of the pathogen to settings such as hospitals can cause outbreaks among vulnerable populations

. The resistance of Staphylococcus aureus to penicillin, through the acquisition of a penicillin-degrading penicillinase plasmid penicillinase, was initially restricted to the hospital setting. Currently, this resistance has spread quickly in community affects more than 90% of strains of S. aureus.

Methicillin resistance is related to the acquisition of another penicillin binding protein, PLP2a. This PLP2a transpeptidase has a low affinity for β-lactams. The production of this PLP2a is encoded by the mec A chromosomal gene [35]. Strains of S. aureus possessing the mec A gene are therefore resistant to the entire family of β-lactams, especially meticillin or oxacillin. The mec A gene is included in a mobile genetic element: the staphylococcal cassette [36]. The strains of MRSA isolated in our study carried mec A gene.

Staphylococcus aureus has a strong adaptive power. It is a formidable pathogen that has developed resistance to each new antibiotic introduced for half a century. The plasticity of its genome gives it the ability to adapt to all environmental conditions, including the acquisition of antibiotic resistance genes other than beta lactamines and to develop regulatory mechanisms to adapt to increasing concentrations of antibiotics [36]. This explains the resistance of MRSA strains to the many families of antibiotics with resistance rates of up to 90-95% for some [36].

In our study, the S. aureus isolates exhibited resistance to Penicillin G resistance (97%), The two strains isolated of CAMRSA were resistant to Cotrimoxazole (100%), Fusidic acid (100%) and Kanamycin (50%). They were susceptible to Glycopeptid, Linézolid and Fluoroquinolones.

Eibach [37] found a high resistance to Penicillin (95.1%), Tetracyclines (53.7%) and Erythromycin (11.4%). Isolated strains were susceptible to Vancomycin and Linézolide.

In the study of Azmawati et al. [26] the majority of strains isolated were sensitive to oxacillin, 94.7% were resistant to penicillin and 50% were sensitive to erythromycin, 95.8% and 72, 9% were the susceptibility rates for doxycycline and ciprofloxacin, respectively. Levels of resistance to voncomycin and clindamycin were low.

Recommendations

There is insufficient evidence to support the routine use of decolonization treatment for nasal carriage of CA-MRSA. CAMRSA management should focus on preventing the spread of infection with emphasis on good hygiene. Good hygiene should emphasize proper hand washing, keeping draining wounds covered, and disinfecting the environment. Topical decolonization achieves short-term decolonization. Decolonizing pre-surgical patients may decrease the rate of postoperative wound infections. Topical decolonization strategies involve the use of antiseptic wipes and/or daily nasal antibiotics. If CA-MRSA decolonization treatment regimens are used, it may be useful to treat close cohorts [38].

For our 2 cases of CA-MRSA, we tried to re-contact the 2 identified nasal carriers of CA-MRSA, a survey was conducted to know the circumstances and experience of both patients, raise awareness and propose an effective treatment to limit the contamination of the environment.

Conclusion

S. aureus is a pathogen whose high adaptability allows survival through the successive acquisition of antibiotic resistance genes, growth-regulating mechanisms in the presence of antibiotics.

Children of consultation in Marrakech, Morocco have a high rate of colonization with S. auerus. Nasal colonization of CAMRSA exists but is still low among children lacking traditional risk factors for MRSA infection. This study has demonstrated the baseline colonization rate, and continued surveillance of this population is necessary to assess the ongoing risk CAMRSA poses to this community. Presence of resistance to commonly used antibiotics is a big concern. Elimination of nasal carriage would theoretically reduce the infection rates in populations in which it has been identified as a risk factor.

The vigilance of clinicians and microbiologists is required to signal the emergence of new epidemiological phenomena.

New studies will be needed to better investigate the other S. aureus porting sites, to better appreciate the colonization dynamics of this bacterium over time and to better specify the risk factors favoring carriage.

Antibiotic surveillance program and infection control strategy should be instituted to monitor the development of antibiotic resistance nationally through clear and feasible implementation strategies to prevent community spread of these community-acquired MRSA.

26432

References

  1. Nhan TX, Gillet Y, Vandenesch F (2012) Diagnostic et traitements des infections toxiniques à Staphylococcus aureus. Journal des Anti-infectieux 14: 117-126.
  2. Vanden Bergh MF, Yzerman EP, van Belkum A (1999) Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J Clin Microbiol 1999; 37: 3133-3140.
  3. Reid MJA, Fischer RSB, Mannathoko N (2017) Prevalence of Staphylococcus aureus Nasal Carriage in Human Immunodeficiency Virus–Infected and Uninfected Children in Botswana: Prevalence and Risk Factors .Published online 2017.
  4. Coombs GW, Monecke S, Pearson JC (2011) Evolution and diversity of community-associated methicillin-resistant Staphylococcus aureus in a geographical region. BMC Microbiol 11: 215.
  5. Shetty V, Trumbull K, Hegde A (2014) Prevalence of community-acquired methicillin-resistant Staphylococcus aureus nasal colonization among children. J Clin Diagn Res 8: DC12-15.
  6. Huang YC, Hwang KP, Chen PY, Chen CJ, Lin TY (2006) Prevalence of Methicillin-Resistant Staphylococcus aureus Nasal Colonization among Taiwanese Children in 2005 and 2006. J Clin Microbiol 45: 3992–3995.
  7. Pan HH, Huang YC, Chen CJ, Huang FL, Ting PJ (2019) Prevalence of and risk factors for nasal methicillin-resistant Staphylococcus aureus colonization among children in central Taiwan. J Microbiol Immunol Infect 52: 45-53.
  8. Kluytmans J, van Belkum A, Verbrugh H (1997) Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10: 505.
  9. Comité de l’antibiogramme de la société française de microbiologie Recommandation 2018.
  10. Caby F, Bismuth R, Bossi P (2010) Infections à staphylocoques. EMC (Elsevier Masson SAS, Paris), Traité de Médecine Akos 1044-1045.
  11. Wertheim HF, Melles DC, Vos MC, Van Leeuwen W, Van Belkum A, et al. (2005) The role of nasal carriage in S.aureus infections. Lancet Infect Dis 5: 751-762.
  12. Kluytmans JAJW, Wertheim HFL (2005) Nasal Carriage of Staphylococcus aureus and Prevention of Nosocomial Infections Infection 33.
  13. Mobasherizadeh S, Shojaei H, Havaei SA, Mostafavizadeh K, Davoodabadi F, et al. (2016) Nasal carriage screening of community-associated methicillin resistant Staphylococcus aureus in healthy children of a developing country 5: 144.
  14. Centers for Disease Control and Prevention (2005) Community associated MRSA information for clinicians. Infection control topics. Centers for Disease Control and Prevention, Atlanta, GA.
  15. Morrison MA, Hageman JC, Klevens RM (2006) Case definition for community-associated methicillin-resistant Staphylococcus aureus. J Hosp Infect 62: 241.
  16. Ramana KV, Mohanty SK, Wilson CG (2009) Staphylococcus aureus colonization of anterior nares of school going children. Indian J Pediatr 76: 813-816.
  17. Mainous A, Hueston W, Everett C (2006) Nasal carriage of Staphylococcus aureus and methicillin-resistant S. aureus in the United States, 2001-2002. Ann Fam Med 4: 132-137.
  18. Clinical and Laboratory Standards Institute (2008) Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. CLSI document M100-18. Wayne, PA: Clinical and Laboratory Standards Institute.
  19. Chatterjee SS, Ray P, Aggarwal A, Das A, Sharma M (2009) A community-based studyonnasal carriage of Staphylococcus aureus. Indian J Med Res130: 742-748.
  20. Zouari A, Smaoui H, Hajji N (2012) Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in tunisian school-aged child. Revue Tunisienne d’Infectiologie 6: 225-231.
  21. Moyo SJ, Aboud S, Blomberg B, Mkopi N, Kasubi M, et al. (2014) High nasal carriage of methicillin-resistant Staphylococcus aureus among healthy Tanzanian under-5 children. 20: 82-88.
  22. Bogaert D, van Belkum A, Sluijter M, Luijendijk A, de Groot R, et al. (2004) Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 363: 1871-1872.
  23. Ko KS, Lee JY, Baek JY, Peck KR, Rhee JY, et al. (2008) Characterization of Staphylococcus aureus nasal carriage from children attending an outpatient clinic in Seoul, Korea. Microb Drug Resist 14: 37-44.
  24. Peacock SJ, Justice A, Griffiths D, de Silva GD, Kantzanou MN, et al. (2003) Determinants of acquisition and carriage of Staphylococcus aureus in infancy. J. Clin. Microbiol. 41: 5718-5725.
  25. Chen CJ, Hsu KH, Lin TY, Hwang KP, Chen PY, et al. (2011) Factors Associated with Nasal Colonization of Methicillin-Resistant Staphylococcus aureus among Healthy Children in Taiwan. J Clin Microbiol 49: 131-137.
  26. Mohamed NA, Ramli S, Amin NNZ, Sulaiman WS, Isahak I, et al. (2016) Staphylococcus aureus carriage in selected kindergartens in Klang Valley .Med J Malaysia 71.
  27. Nikfar R, Shamsizadeh A, Kajbaf TZ, Panah MK, Khaghani S, et al. (2015) Frequency of methicillin-resistant Staphylococcus aureus nasal carriage in healthy children 7: 67-71.
  28. Laub K, Tothpal A, Kovacs E, Sahin-Toth J, Horvath A, et al. (2018) High prevalence of Staphylococcus aureus nasal carriage among children in Szolnok, Hungary. Acta Microbiol Immunol Hung 65: 59-72.
  29. Dey S, Rosales-Klintz S, Shouche S, Pathak JP, Pathak A (2013) Prevalence and risk factors for nasal carriage of Staphylococcus aureus in children attending anganwaries (preschools) in Ujjain, India. BMC Res Notes 6: 265.
  30. Lo WT, Lin WJ, Tseng MH, Lu JJ, Lee SY, et al. (2007) Nasal carriage of a single clone of community-acquired methicillin-resistant Staphylococcus aureus among kindergarten attendees in northern Taiwan. BMC Infect Dis 7: 51.
  31. Nakamura M, Rohling K, Shashaty M, Lu H, Tang Y, et al. (2002) Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community paediatric population. Pediatr Infect Dis J 21: 917-921.
  32. Creech CB, Kernodle DS, Alsentzer A, Wilson C, Edwards KM (2005) Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J 24: 617-621.
  33. CDC (2006) Community-associated methicillin-resistant Staphylococcus aureus infection among healthy newborns Chicago and Los Angeles County, 2004. MMWR Morb Mortal Wkly Rep 55: 329-332.
  34. Salgado CD, Farr BM, Calfee DP (2003) Community-acquired methicillin-resistant Staphylococcus aureus:ameta-analysis of prevalence and risk factors. Clin Infect Dis 36: 131-139.
  35. Ito T, Okuma K, Ma XX, Yuzawa H, Hiramatsu K (2003) Insights on antibiotic resistance of Staphylococcus aureus from its whole genome : genomic island SCC. Drug Resist Updat 6: 41-52.
  36. Le Coutumier A, Geudet P, Lecaillon E (1996) Staphylococcus aureus méticillinorésistant : Passé, présent, futur 1re et 2e partie. SpectraBiol 79: 22-27.
  37. Eibach D, Nagel M, Hogan B, Azuure C, Krumkamp R, et al. (2017) Nasal Carriage of Staphylococcus aureus among Children in the Ashanti Region of Ghana 12: e0170320.
  38. Tidwell J, Kirk L, Luttrell T, Pike CA (2016) CA-MRSA Decolonization Strategies. Journal of Wound Ostomy and Continence Nursing 43: 577-582.